Clinical Trial Update: Safety Study of UT-15C SR (Oral Treprostinil) in Patients Undergoing a Lower Limb Endovascular Procedure [Phase 2]

View source ↗

Summary

A Phase 2 safety study of UT-15C SR (oral treprostinil) in patients undergoing a lower limb endovascular procedure for critical limb ischemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Drugs mentioned

• UT-15C SR

Snippet

Sponsor: Ochsner Health System | Conditions: Critical Limb Ischemia | Phase 2 | Status: COMPLETED